Fortress Biotech (FRA:CNB1) Total Assets : €151.47 Mil (As of Mar. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Fortress Biotech Total Assets?

Fortress Biotech's Total Assets for the quarter that ended in Mar. 2024 was €151.47 Mil.

Warning Sign:

If a company builds assets at 8% a year, faster than its revenue growth rate of 4.6% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, Fortress Biotech's average Total Assets Growth Rate was -27.20% per year. During the past 3 years, the average Total Assets Growth Rate was -4.70% per year. During the past 5 years, the average Total Assets Growth Rate was 8.00% per year. During the past 10 years, the average Total Assets Growth Rate was 36.00% per year.

During the past 13 years, Fortress Biotech's highest 3-Year average Total Assets Growth Rate was 349.80%. The lowest was -4.70%. And the median was 28.85%.

Total Assets is connected with ROA %. Fortress Biotech's annualized ROA % for the quarter that ended in Mar. 2024 was -37.19%. Total Assets is also linked to Revenue through Asset Turnover. Fortress Biotech's Asset Turnover for the quarter that ended in Mar. 2024 was 0.08.

Fortress Biotech Total Assets Historical Data

The historical data trend for Fortress Biotech's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fortress Biotech Total Assets Chart

Fortress Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

203.78

274.07

350.91

277.82

153.62

Fortress Biotech Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Assets	Get a 7-Day Free Trial															246.16	166.80	141.06	153.62	151.47

Fortress Biotech Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Fortress Biotech's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	1.455	+	152.166
	=	153.62

Fortress Biotech's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2024 )	+	Total Liabilities (Q: Mar. 2024 )
	=	-3.622	+	155.095
	=	151.47

Fortress Biotech (FRA:CNB1) Total Assets Explanation

Total Assets is connected with ROA %.

Fortress Biotech's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %	=	Net Income (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
	=	-56.736	/	( (153.621	+	151.473)	/ 2 )
	=	-56.736	/	152.547
	=	-37.19 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Fortress Biotech's Asset Turnover for the quarter that ended in Mar. 2024 is

	Asset Turnover
=	Revenue (Q: Mar. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Mar. 2024 ))	/ count )
=	11.988	/	( (153.621	+	151.473)	/ 2 )
=	11.988	/	152.547
=	0.08

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Fortress Biotech Total Assets Related Terms

Thank you for viewing the detailed overview of Fortress Biotech's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Fortress Biotech (FRA:CNB1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Fortress Biotech Inc (FRA:CNB1) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

FBIOP.PFD:USA FBIO:USA CNB0.PFD:Germany

Address

1111 Kane Concourse, Suite 301, Bay Harbor Island, FL, USA, 33154

Website

https://www.fortressbiotech.com

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

Fortress Biotech (FRA:CNB1) Headlines

No Headlines